Cargando…
Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation
Up to 50% of systemic lupus erythematosus (SLE) patients world-wide develop lupus nephritis (LN). In low to middle income countries and in particular in sub-Saharan Africa, where SLE is prevalent with a more aggressive course, LN and end stage renal disease is a major cause of mortality. While devel...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518293/ https://www.ncbi.nlm.nih.gov/pubmed/37626268 http://dx.doi.org/10.1007/s10787-023-01321-x |